Deeptashree Nandi

发表

Drug Resistance in Cancer and Role of Nanomedicine-Based Natural Products

Deeptashree Nandi, Aakriti Singal, A. Nag, 2019, Bioactive Natural Products for the Management of Cancer: from Bench to Bedside.

Identification of novel interaction between Promyelocytic Leukemia protein and human Alteration/Deficiency in Activation 3 coactivator and its role in DNA damage response

S. Aggarwal, Deeptashree Nandi, A. Nag, 2019, Journal of Proteins and Proteomics.

The Anaphase Promoting Complex/ cyclosome co-activator, Cdh1, is a novel target of human Papillomavirus 16 E7 oncoprotein in cervical oncogenesis

Deeptashree Nandi, A. Nag, P. Cheema, 2021, bioRxiv.

Artemisinin Mediates Its Tumor-Suppressive Activity in Hepatocellular Carcinoma Through Targeted Inhibition of FoxM1

Deeptashree Nandi, Aakriti Singal, A. Nag, 2021, Frontiers in Oncology.

FoxM1: Repurposing an oncogene as a biomarker.

Deeptashree Nandi, A. Nag, P. Cheema, 2017, Seminars in cancer biology.

Exploring the therapeutic potential of forkhead box O for outfoxing COVID-19

Deeptashree Nandi, A. Nag, P. Cheema, 2021, Open Biology.

Significance of Human Microbiome in Breast Cancer: Tale of an invisible and an invincible.

Deeptashree Nandi, A. Nag, Jatin Chadha, 2020, Seminars in cancer biology.

The pint- sized powerhouse: Illuminating the mighty role of the gut microbiome in improving the outcome of anti- cancer therapy.

I. Chattopadhyay, Deeptashree Nandi, A. Nag, 2020, Seminars in cancer biology.

Tale of a multifaceted co-activator, hADA3: from embryogenesis to cancer and beyond

Deeptashree Nandi, A. Nag, Vaibhav Chand, 2016, Open Biology.

Toxicity assessment of plants raised in sludge amended soil.

S. Sultana, B. Dhir, A. Wafa, 2017 .

The gut microbiota in breast cancer development and treatment: The good, the bad, and the useful!

D. Sharma, S. Parida, Deeptashree Nandi, 2023, Gut microbes.